Bacteriophage Compositions and Methods of Selection of Components Against Specific Bacteria
US-2017368116-A1 · Dec 28, 2017 · US
Shigatoxin-producing F18 type E. coli bacteriophage esc-COP-1 and use thereof for inhibiting proliferation of shigatoxin-producing F18 type E. coli
US10265355B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10265355-B2 |
| Application number | US-201515538573-A |
| Country | US |
| Kind code | B2 |
| Filing date | Dec 28, 2015 |
| Priority date | Dec 30, 2014 |
| Publication date | Apr 23, 2019 |
| Grant date | Apr 23, 2019 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present invention relates to a Myoviridae bacteriophage Esc-COP-1 that is isolated from the nature and can kill specifically Shigatoxin-producing type F18 E. coli strains, which has a genome represented by the nucleotide sequence of SEQ. ID. NO: 1 (Accession NO: KCTC 12662BP), and a method for preventing and treating the infections of Shigatoxin-producing type F18 E. coli using the composition comprising said bacteriophage as an active ingredient.
First claim
Opening claim text (preview).
What is claimed is: 1. A method for preventing or treating infections of Shigatoxin-producing type F18 E. coli , the method comprising a step of administering to a subject a composition comprising Myoviridae bacteriophage Esc-COP-1 (Accession NO: KCTC 12662BP) that is isolated from nature and can kill Shigatoxin-producing type F18 E. coli specifically, which has the genome represented by the nucleotide sequence of SEQ ID NO: 1, as an active ingredient. 2. The method according to claim 1 , wherein said composition is administered to the subject in the form of a feed additive, a drinking water additive, or a disinfectant.
Assignees
Inventors
Classifications
Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent · CPC title
Viruses as such, e.g. new isolates, mutants or their genomic sequences · CPC title
- C12N7/00Primary
Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof (preparing medicinal viral antigen or antibody compositions, e.g. virus vaccines, A61K39/00) · CPC title
Use of specific compounds during water treatment · CPC title
Disinfection · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US10265355B2 cover?
- The present invention relates to a Myoviridae bacteriophage Esc-COP-1 that is isolated from the nature and can kill specifically Shigatoxin-producing type F18 E. coli strains, which has a genome represented by the nucleotide sequence of SEQ. ID. NO: 1 (Accession NO: KCTC 12662BP), and a method for preventing and treating the infections of Shigatoxin-producing type F18 E. coli using the composit…
- Who is the assignee on this patent?
- Intron Biotechnology Inc
- What technology area does this patent fall under?
- Primary CPC classification C12N7/00. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue Apr 23 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 12 related publications on this page (citations in our corpus or others sharing the same primary CPC).